IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo
- PMID: 8350046
- PMCID: PMC2191174
- DOI: 10.1084/jem.178.3.1057
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo
Abstract
IP-10 is a member of the -C-X-C-chemokine superfamily of proinflammatory cytokines whose secretion is induced by interferon gamma (IFN-gamma) and lipopolysaccharide (LPS). To date no function has been described for IP-10. We have genetically engineered tumor cells to secrete high levels of murine IP-10 and demonstrate that while IP-10 has no effect on the growth of these tumor cells in culture, it elicits a powerful host-mediated antitumor effect in vivo. The IP-10 antitumor response is T lymphocyte dependent, non-cell autonomous, and appears to be mediated by the recruitment of an inflammatory infiltrate composed of lymphocytes, neutrophils, and monocytes. These results document an important biologic property of IP-10 and raise the possibility that some of the T cell-directed effects of IFN-gamma and LPS may be mediated by this chemokine.
Similar articles
-
Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils.Eur J Immunol. 1997 Jan;27(1):111-5. doi: 10.1002/eji.1830270117. Eur J Immunol. 1997. PMID: 9022006
-
Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors.J Immunother. 2001 Mar-Apr;24(2):138-43. J Immunother. 2001. PMID: 11265771
-
Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.J Leukoc Biol. 2006 Dec;80(6):1434-44. doi: 10.1189/jlb.0306212. Epub 2006 Sep 15. J Leukoc Biol. 2006. PMID: 16980511
-
Mig and IP-10: CXC chemokines that target lymphocytes.J Leukoc Biol. 1997 Mar;61(3):246-57. J Leukoc Biol. 1997. PMID: 9060447 Review.
-
The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily.Cytokine Growth Factor Rev. 1997 Sep;8(3):207-19. doi: 10.1016/s1359-6101(97)00015-4. Cytokine Growth Factor Rev. 1997. PMID: 9462486 Review.
Cited by
-
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma.Br J Cancer. 2012 Nov 6;107(10):1729-36. doi: 10.1038/bjc.2012.456. Epub 2012 Oct 11. Br J Cancer. 2012. PMID: 23059742 Free PMC article.
-
CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.PLoS One. 2010 Sep 13;5(9):e12700. doi: 10.1371/journal.pone.0012700. PLoS One. 2010. PMID: 20856926 Free PMC article.
-
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17655-60. doi: 10.1073/pnas.1101133108. Epub 2011 Oct 11. Proc Natl Acad Sci U S A. 2011. PMID: 21990345 Free PMC article.
-
Investigation of immunosuppressive mechanisms in a mouse glioma model.J Neurooncol. 2009 May;93(1):107-14. doi: 10.1007/s11060-009-9884-6. Epub 2009 May 9. J Neurooncol. 2009. PMID: 19430886
-
Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10.Acta Pharmacol Sin. 2009 Feb;30(2):193-201. doi: 10.1038/aps.2008.24. Epub 2009 Jan 19. Acta Pharmacol Sin. 2009. PMID: 19151743 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources